Anti-idiotypic antibodies induced by genetic immunisation are directed exclusively against combined VL/VH determinants

Gene Therapy

Volumn 8, Issue 20, 2001, Pages 1555-1561

  Benvenuti, F ^a,b   Burrone, O R ^a  

^a INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^b INSTITUT CURIE   (France)

Author keywords

Anti idiotypic antibodies; DNA vaccination; Lymphoma immunotherapy

Indexed keywords

ANTIGEN; ANTIIDIOTYPIC ANTIBODY; ANTISERUM; CHIMERIC PROTEIN; DNA VACCINE; EPITOPE; IDIOTYPIC ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN IDIOTYPE; IMMUNOGLOBULIN LIGHT CHAIN; MEMBRANE ENZYME; POLYCLONAL ANTIBODY; SECRETORY COMPONENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B CELL LYMPHOMA; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; GENETIC CODE; GENETICS; IMMUNIZATION; IMMUNOGLOBULIN VARIABLE REGION; MAMMAL CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; STRUCTURE ANALYSIS; TUMOR GROWTH; TUMOR REJECTION;

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; B-LYMPHOCYTES; BASE SEQUENCE; BLOTTING, WESTERN; CLONING, MOLECULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETIC ENGINEERING; IMMUNOGLOBULIN IDIOTYPES; IMMUNOGLOBULIN VARIABLE REGION; IMMUNOTHERAPY, ACTIVE; LYMPHOMA; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; MOLECULAR SEQUENCE DATA; TRANSFECTION; TUMOR CELLS, CULTURED; VACCINES, DNA;

EID: 0035172467     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gt.3301546     Document Type: Article

References (29)

1. Idiotype vaccination against murine B cell lymphoma: Humoral and cellular responses elicited by tumour derived IgM and its molecular subunits
2. Idiotype vaccination against murine B cell lymphoma: Inhibition of tumour immunity by free idiotype protein
3. Idiotypic vaccination as a treatment for a B cell lymphoma
4. DNA immunisation induces protective immunity against B-cell lymphoma
5. A nine ammino acid peptide from IL-1b aguments anti-tumour immune responses induced by protein and DNA vaccines
6. DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma
7. Anti-idiotypic DNA vaccines for lymphoma immunotherapy require the presence of both variable region genes for tumour protection
8. Monoclonal antibody therapy of B cell lymphoma: Signaling activity on tumour cells appears more important than recruitment of effectors
9. The importance of antibody-specificity in determining successful radioimmunotherapy of B-cell lymphoma
10. Quaternary structure-dependent idiotype and antigen binding of a monoclonal antibody specific for conformational epitope on type II collagen
11. Both VH and VL regions contribute to the antigenicity of anti-idiotypic antibody that mimics melanoma associated ganglioside GM3
12. A single amino acid mutation in CDR3 of the 3-14-9 L chain abolished expression of the IDA 10-defined idiotype and antigen binding
13. Structural definition by antibody engineering of an idiotypic determinant
14. VH-related idiotopes detected by site directed mutagenesis
15. Molecular characterisation of a cross-reactive idiotope on human immunoglobulin utilizing the VH4-21 gene segment
16. Structure of idiotypes associated with antiphenylarsonate antibodies expressing an intrastrain crossreactive idiotype
17. Mammalian cell expression of dimeric small immune proteins (SIP)
18. Molecular cloning and characterization of a transmembrane surface antigen in human cells
19. The two membrane isoform of human IgE assemble into functionally distinct B cell antigen receptors
20. Membrane immunoglobulins are stabilised by inter-chain disulphide bonds occurring within the extracellular membrane-proximal domain
21. Monoclonal antibodies raised against the idiotype of the murine B cell lymphoma BCL1 act primarily with heavy chain determinants
22. DNA vaccination against the idiotype of a murine B cell lymphoma: Mechanism of tumour protection
23. Linkage of foreign carrier protein to a self-tumour antigen enhances the immunogenicity of a pulsed dendritic cell vaccine
24. Setting the standards: Quality control in the secretory pathway
25. Analysis of the interaction of monoclonal antibodies with surface IgM on neoplastic B-cells
26. Analysis of the interaction of antibodies with immunoglobulin idiotypes on neoplastic B lymphocytes: Implications for immunotherapy
27. Evidence for an upper affinity threshold for anti-IgM-induced apoptosis in a human B-cell lymphoma
28. Spontaneous murine B-cell leukaemia
29. Characterization of a second secreted IgE isoform and identification of an asymmetric pathway of IgE assembly